Safety, Tolerability, and Pharmacokinetics of 2‐Pyridylacetic Acid, a major metabolite of betahistine, in Phase 1 dose escalation study in subjects with ADHD

This article is protected by copyright. All rights reserved.

Source: Biopharmaceutics and Drug Disposition - April 22, 2015 Category: Drugs & Pharmacology Authors: Ganesh Moorthy, Floyd Sallee, Prasad Gabbita, Frank Zemlan, Larry Sallans, Pankaj B. Desai Tags: Original Paper Source Type: research